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Abstract
Background: In the last decades, a wide number of researchers/clinicians involved in tissue engineering field
published several works about the possibility to induce a tissue regeneration guided by the use of biomaterials. To
this aim, different scaffolds have been proposed, and their effectiveness tested through in vitro and/or in vivo
experiments. In this context, integration and meta-analysis approaches are gaining importance for analyses and
reuse of data as, for example, those concerning the bone and cartilage biomarkers, the biomolecular factors
intervening in cell differentiation and growth, the morphology and the biomechanical performance of a neo-
formed tissue, and, in general, the scaffolds’ ability to promote tissue regeneration. Therefore standards and
ontologies are becoming crucial, to provide a unifying knowledge framework for annotating data and supporting
the semantic integration and the unambiguous interpretation of novel experimental results.
Results: In this paper a conceptual framework has been designed for bone/cartilage tissue engineering domain, by
now completely lacking standardized methods. A set of guidelines has been provided, defining the minimum
information set necessary for describing an experimental study involved in bone and cartilage regenerative
medicine field. In addition, a Bone/Cartilage Tissue Engineering Ontology (BCTEO) has been developed to provide
a representation of the domain’s concepts, specifically oriented to cells, and chemical composition, morphology,
physical characterization of biomaterials involved in bone/cartilage tissue engineering research.
Conclusions: Considering that tissue engineering is a discipline that traverses different semantic fields and
employs many data types, the proposed instruments represent a first attempt to standardize the domain
knowledge and can provide a suitable means to integrate data across the field.
Background
Several tissue engineering approaches have been pro-
posed in the last years with the aim to mimic the nat-
ural processes of tissue regeneration (such as bone and
cartilage), by delivering progenitor cells capable of dif-
ferentiating into osteoblasts and chondrocytes inductive
molecules and bioactive three-dimensional scaffolds sup-
porting cellular colonization and matrix deposition [1].
In the last decades, a wide number of in vitro and in vivo
experiments have been carried out in order to test new
scaffolds able to guide the process of ex vivo connective tis-
sue formation. Experimental preclinical models showed
promising results of high scientific interest. However, this
approach is far from being considered optimal and
mechanisms of tissue formation/remodelling are still not
completely elucidated. In particular the cell differentiation
process has not been clarified yet, as well as the scaffold
features that can positively or negatively influence the cellu-
lar fate and, finally, the tissue growth [1]. The identification
of biological processes that take place in tissue-engineered
constructs could in fact help to further understand the
observed mechanism of tissue regeneration. The obtained
information can also be useful for improvements in scaffold
design through a reverse engineering approach [2].
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The complexity of these interdisciplinary studies is
even increased by the generation of various types of
data at various level of detail, and by the lack of concept
models and software infrastructure helping data man-
agement and exploitation. In particular, technical details
about experiments reported in literature are often scarce
and barely accessible to point out the functional effec-
tiveness of tested materials. Systematic reviews and
meta-analyses approaches are often based on public
scientific literature, thus requiring concepts definition
and standardization.
Informatics tools are necessary to organize, and favour
accessibility, integration, interoperability and sharing of
data, which regards multiple and diverse scientific
aspects, such as the presence and/or quantification of
bone and cartilage biomarkers, the biomolecular factors
intervening in cell differentiation and growth, the mor-
phology and the biomechanical performance of a neo-
formed tissue, and, in general, the scaffolds’ ability to
promote tissue regeneration. In this work a conceptual
framework is presented for bone and cartilage tissue
engineering domain: authors have defined practical
guidelines to drive a structured, reliable and complete
method for publishing and sharing (in journals’ papers
and web based resources) data coming from tissue engi-
neering experiments. Moreover, an ontology, defined as
a set of representational primitives suitable to model a
domain of knowledge [3], has been developed, to pro-
vide a hierarchically structured recognized vocabulary
for data explanation, classification and query. The over-
all framework has been validated with the help of an
end user, to guarantee its effectiveness and usability for
the tissue engineering community. The Bone/Cartilage
Tissue Engineering Ontology (BCTEO) is available at
http://bioportal.bioontology.org/ontologies/BCTEO.
Related work
Data standardization is a rapidly growing area of research,
especially in life sciences domain. It represents the basis
for data exchange, queries support, publication of reusable
knowledge bases and interoperability facilitated across
multiple and heterogeneous systems and databases.
Standards for structuring data related to the biological
field have been proposed, to treat different types of data.
In particular, guidelines have been suggested for many
aspects of molecular biology defining the minimum set of
information (metadata) needed to unambiguously describe
experiments and data (for reproduction and interpreta-
tion). Major examples of this approach are presented in
Table 1.
For what concerns ontologies, biomedical research area
is rich of structured vocabularies and tools to manage
them. Ontologies have been developed for genes, proteins,
tissues, cells, chemical compounds, anatomy etc. The most
used facilities for ontologies consulting and screening
are OboFundry [4], NCBO BioPortal [5], OLS [6] and
OntoBee [7], which collect many of the existing ontologies
in obo and owl formats and provide access to them
through searching and browsing facilities.
Nevertheless, no standardization approaches have been
developed for tissue engineering. The only semantic instru-
ments provided in this field at the moment seem to be: (1)
for what concerns bone domain, the Bone Dysplasia Ontol-
ogy [8], a comprehensive and formal representation of the
skeletal dysplasia domain and related genotypes and
phenotypes; and the EVENT-INOH pathway ontology
(IEV) [9], used to annotate biological processes, pathways
and sub-pathways, where some terms related to growth
and tissue regeneration appear; (2) for what concerns
material subject, the Nanoparticle Ontology (NPO) [10],
describing concepts from the field of cancer nanomaterials.
Methods
Tissue engineering context
Adult stem cells demonstrated their multipotency leading
to the formation of cartilage, bone, muscle, connective
tissue or fat [11].
Autologous stem cells are routinely used in conventional
tissue engineering ex vivo in combination with biomater-
ials to create a cell-based scaffold for replacing or improv-
ing the tissue regeneration in vivo. Briefly, cells are
typically harvested from donor tissues, isolated and
expanded in culture and then associated with biomaterials
both of synthetic and biological origin. The cell-material
construct may be either cultured in vitro or implanted in
vivo, using selectively an ectopic or orthotropic animal
model.
In this context, biomaterials have to provide informa-
tive microenvironments: material intrinsic nature and
structure will anyway transmit a signal that has to be
decoded by the colonizing cells and converted into active
cellular response. A simplified schema of bone/cartilage
tissue engineering approach is shown in Figure 1.
Ontology approach
The list of minimum information to explain experiments
about connective tissue growth on substitute materials
has been identified by means of the expertise that authors
gained in tissue engineering and in data management and
integration. Relying on this experience, literature was
manually overviewed for identifying recurrent concepts
in papers. A primary list was then enriched with addi-
tional information that is often lacking in many published
contributions but that appears basic for a correct and
complete data report.
On the base of the identified guidelines, which schema-
tically point out macro-areas of the domain, BCTEO has
been designed. An ontology is the formal specification of
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a conceptualization of domain, which consists of a com-
mon vocabulary and logical structure providing knowledge
framework for annotation, semantic integration, knowl-
edge-based searching and unambiguous interpretation of
data [12]. It provides a hierarchical formal representation
of a set of concepts through the description of: (1) indivi-
duals, which are the basic objects, (2) classes, that are the
categories which objects belong to, (3) attributes, which
are the features of the objects, and (4) relations, that are
the ways objects can be related one another.
BCTEO was developed with the OBO-Edit software in
the OBO format [13], the most common format for
ontologies in biomedical research field. It is a textual for-
mat that attempts to guarantee human readability, ease
Figure 1 Simplified schema of the bone/cartilage tissue engineering approach. Cells extracted from a donor tissue are expanded and
seeded in a biomaterial. Tissue growth (and cell differentiation, if starting from stem cells) can be evaluated either in vitro or in vivo. In the
latter case, implant can be in ectopic or orthotopic mode, depending on the size of the model organism and the necessity to evaluate the
biomechanical stress on the tissue.
Table 1 Examples of standards suggesting minimum sets of metadata.
MiMix [21] Minimum Information required for reporting a Molecular Interaction experiment
It relies on PSI-MI [22] controlled vocabularies for terms, and its purpose is providing a checklist of the information to be supplied when describing
experimental molecular interaction data. It is a module developed within the framework of the MIAPE guidelines.
MIAPE [23] Minimum Information About a Proteomics Experiment
It provides guidance modules for reporting the use of proteomics techniques such as gel electrophoresis and mass spectrometry, and has been
developed and proposed to encourage collection and integration of these kinds of data.
MIAME [24] Minimum Information About a Microarray Experiment
It is used to submit fully compliant datasets, to enable the interpretation of the experimental results unambiguously and, potentially, to reproduce
the study.
MIRIAM Registry [25] Minimum Information Required in the Annotation of Models
Created for defining the meta-information needed to ensure the re-usability of computational models of biological processes. It aims to maintain,
unambiguously and perennially, the identifiers regarding the biomedical domain. The registry retrieves the identifiers in the form of URIs, and
provides the http://www.Identifiers.org resolver online service, for their generation.
Standards have been provided for different fields of molecular biology, reporting the minimum set of information needed to report experiments details and data,
in order to enable data reproducibility and interpretation.
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of parsing, extensibility and minimal redundancy by rely-
ing on a list of “stanza”. A stanza consists of a name in
square brackets (i.e. [Term] for classes or [Typedef] for
relations), followed by a series of new-line separated “tag:
value” pairs.
To improve the process of ontology creation, authors
followed the steps provided by Noy and McGuinness [14]
and consisting in: clearly defining the domain and the
aim of the project; reusing the existing ontological terms;
identifying main terms of the ontology; defining hierar-
chies and relationships among terms; avoiding inconsis-
tencies. For ontology definition, a top-down approach
has been used, by manually screening literature to infer
main concepts, and then by increasing the level of detail
introducing further in-depth specifications.
For what concerns ontology validation, two aspects
have been considered: structure and concepts validation.
Structure validation, that regards the consistency of the
relations among terms, is guaranteed by the exploitation
of the OBO-Edit internal “reasoner”, a tool that automa-
tically helps to identify formal errors in the ontology.
Concepts validation, which is related to the evaluation of
the correctness of the terms inserted in the ontology and
their definitions, has been assured by authors’ expertise
in tissue engineering and strengthened by supervision of
skilled end-users (see Tools validation section below).
Ontological cross-reference
Due to the multidisciplinarity of tissue engineering field,
many terms crucial for BCTEO were found already clas-
sified and defined in other ontologies. The identification
of cross-references among ontologies was aimed to avoid
redundancy and terms duplication, to simplify vocabul-
aries exploitation and link among partially overlapping
domains. Structured vocabularies containing useful con-
cepts for BCTEO development, and intervening in it, are
described in Table 2.
Terms already included in other ontologies have been
treated as follows: (1) the value of their namespace has
been inherited from the already existing ontology; (2) the
term definition is retrieved from the existing one; (3) the
term identifier of the already existing ontology is recorded
in the ‘xref’ field, in order to indicate term reuse.
Results
The value of biological data and the wish to reuse informa-
tion to infer novel knowledge brought to increase data
sharing and exchange in various biological fields. Other
Table 2 Structured vocabularies useful for BCTEO
Name Acronym Definition Ref.
Brenda Tissue Ontology BTO For the source of an enzyme: it comprises terms for tissues, cell lines, cell types and cell




CARO For facilitating the interoperability between existing anatomy ontologies of different species,
and providing a template for building new anatomy ontologies.
[27]
Chemical Entities of Biological
Interest
CHEBI For chemical compounds of biological relevance. [28]
Cell Type CL For cell types. [29]
eagle-i research Resource
Ontology
ERO For instruments, protocols, reagents, animal models and biospecimens. [30]
Gene Ontology GO For the annotation of gene products with respect to their molecular function, cellular
component, and biological role.
[31]
Protein-protein interaction MI For the annotation of experiments concerned with protein-protein interactions. [32]
Measurement Method Ontology MMO For representing the variety of methods used to make qualitative and quantitative clinical
and phenotype measurements both in the clinic and with model organisms.
[33]
Microarray and Gene Expression
Data Ontology
MO Concepts, definitions, terms, and resources for standardized description of a microarray
experiment
[34]
Medical Subject Headings (MeSH) MSH Terms from National Library of Medicine. [35]
NCI Thesaurus NCI
Thesaurus





OBI For investigations: protocols and instrumentation, material, data generated and types of
analysis performed on it.
[37]
Phenotype and Trait Ontology PATO For phenotypes. Examples of qualities are red, ectopic, high temperature, fused, small,
edematous and arrested.
[38]
Physician Data Query PDQ Wide range of cancer topics, a listing of some 30,000 cancer clinical trials from around the
world, a directory of genetics services professionals, the NCI Dictionary of Cancer Terms, and




SNOMEDCT For medical terms that are used internationally for recording clinical information. They are
coded in computer processable mode.
[40]
NCBI organismal classification TAXON Taxonomic classification of living organisms and associated artifacts. [41]
All of them are available for browsing in the NCBO BioPortal web site.
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than influencing the creation of always more efficient sto-
rage infrastructures, this led to demand for standards and
vocabularies suitable to enable data compatibility and com-
parability. Currently, the tissue engineering research field is
completely unsupplied with informatics instruments
to homogenize information and promote meta-analysis.
For filling this lack, (1) an information model, for domain
structuring, and (2) an ontology, for domain description,
have been developed for bone/cartilage tissue engineering
applications.
The conceptual framework
Authors’ experience in tissue engineering enabled gener-
ating a critical view about publications in this research
field. Commonly, provided data and metadata do not
rely on standardized information sharing schemas, limit-
ing possibilities of data exchange, replication and reuse.
To answer the need for standardization, a conceptual
framework has been proposed, which provides a struc-
ture for communicating observations and improving the
quality of the contents exposed in a scientific paper.
This would facilitate the comprehension of the exposed
concepts by readers, the information extraction and the
classification of knowledge. Data generated in tissue
engineering field are usually complex, due to the high
number of variables intervening in the study, and would
be meaningless unless a defined standard states which
types of data are needed to support and verify conclusions.
The identified macro-areas are: (1) ‘Material’: the identity
of the scaffold material and its properties; (2) ‘Cell’: the
type of used cells and the donor; (3) ‘In vitro experiments’:
cells treatment before seeding including quantities, times
and growth factors addition; (4) ‘In vivo experiments’: host
and implant model; (5) ‘Results’: outcome description,
consisting in the evaluation and report of the matrix
deposition/tissue generation, the material resorption/
degradation or adverse effects, such as cytotoxycity;
(6) ‘Tissue/matrix characterization’: morphology, mechani-
cal, biomolecular and biochemical tests to characterize the
neo-formed tissue/matrix and to obtain a qualitative and
quantitative evaluation of the scaffold performances.
On this basis, the set of minimum information needed
to communicate experiments’ setup and results has been
developed, and detailed in Table 3. The most important
aspect of the provided framework is the results explana-
tion. Many techniques exist for assessing it: (1) tissue/
matrix structure is commonly evaluated through histology,
scanning electron microscopy (SEM), transmission elec-
tron microscopy (TEM) or micro-computed tomography
(MicroCT) technologies; (2) biomechanical tissue/matrix
performances are usually tested through atomic force
microscopy (AFM) or dynamic mechanical analysis
(DMA) approaches; (3) biomolecular/biochemical aspects
can be achieved using histochemistry to highlight content
of calcium and glycosaminoglycans in tissue/matrix, or
real-time reverse-transcription polymerase chain reaction
(real time RT-PCR) and immune-based approaches like
immunohistochemistry (IHC) or immunofluorescence
(IHF) for detecting biomolecules. The last techniques can
target specific, a priori determined, genes and/or proteins,
known to be involved in bone (i.e. RUNX2, BSP, ALP,
OPN, OC, ON, COL1A1) or cartilage (i.e. COL1A1,
COL2A1, COL10A1, ACAN, SOX9) formation. Recently
high-throughput techniques such as gene expression
microarray and mass spectrometry are beginning to be
exploited even in this research field, with the aim of
obtaining the whole expression profile and helping the
characterization of the biomolecular cellular response [15].
This approach is valuable especially when working with
human stem cells, because it allows the determination of
the biochemical factors involved in cell differentiation and
tissue growth, according to the features of the considered
artificial grafts and the provided cues.
The connective tissue engineering ontology
In order to provide roadmaps for data structuring in con-
nective tissue engineering field, a finer informatics tool has
been developed: BCTEO. Ontologies represent a source of
standardized and recognised descriptive terms: a term
belonging to a controlled vocabulary is more precise in the
meaning in respect to free-text, since it presents a well
established, commonly accepted definition, and a set of
synonyms. Furthermore, an ontology is characterized by
the relationships among terms, that help for data classifi-
cation and annotation, semantic based information search
(allowing efficient queries), and even inference of new rela-
tions among data.
The core of BCTEO conceptually refers to the guide-
lines proposed in the previous section and it is organized
into five main classes: Biomaterial, Experiments, Organ-
ism, Tissue, Cellular response. Classes interact at various
levels to model the knowledge about bone and cartilage
substitute materials.
For correctly describing the interactions among ontology
classes, new relations have been defined. Additionally to
Relation Ontology (RO) [16] terms (is_a, part_of, derives_
from), BCTEO relies on two novel relations: ‘characterizes’
and ‘intervenes_in’. The ‘characterizes’ relation is a general
mechanism to represent named attributes. An attribute-like
term is related to an ontology term in order to claim its
qualities. At best of authors’ knowledge no relation exists
to link qualities to a term of the ontology. ‘characterizes’
formal definition is: A characterizes C if and only if: given
any c that instantiates C (at time t for continuant), there is
a that instantiates A (at time t) and a *characterizes* c,
where *characterizes* is an instance-level characterization
relation. An example of its usage in BCTEO is: Intrinsic
properties characterizes Biomaterial. The ‘intervenes_in’
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Table 3 The designed conceptual framework
Sections Features Details
Material Material Type of support material for tissue regeneration exploited in the described experiment.
Material group Cluster of biomaterials the selected one belongs to: metals, polymers, ceramics, gels, composites,
or other.
Features Morphological and chemico-physical characteristics of the material: bulk properties (total porosity,
pore shape and size, pore size distribution, pores volume, pore interconnection); surface
properties (chemical/physical functionalization); scaffold properties (sample size and shape
[optional]); mechanical properties (such as Bulk modulus and maximum strain) [optional]; chemico-
physical properties (such as resorbability and thermoplasticity) [optional].
Cell Cells type Type of cells seeded on the biomaterial, both specifying: the type of cells (for example fibroblasts,
osteoblasts, chondrocytes); if they are cell lines (reporting the specific cell line code) or primary
cells; in this case, the related extraction protocol.
Donor organism Species of organism the cells derive from.
Donor features Age, gender, weight and health status of the donor.
In vitro experiment Cell expansion phase Time or number of expansions (passages) the cells underwent in plate before being seeded in
the biomaterial; type of culture medium used during cell expansion; list of the growth factors that
have been added to the cell expansion; for each growth factor, the concentration (mg/ml or Mol)
must be reported, together with its isoform, if it exists (as in the case of the Transforming Growth
Factor-beta isoforms, which play critical roles in growth regulation and development), and the
organism species the growth factor comes from.
Cell culture phase onto
the biomaterial
Number (cell quantity) or concentration (number of cells per unit of volume) of cells seeded in
the biomaterial; cell seeding efficiency; type of culture medium used during cell culture onto the
material; cell culture time; list of the growth factors that have been added to the cell culture onto
the biomaterial; for each growth factor, the concentration (mg/ml or Mol) must be reported,
together with its isoform, if it exists (as in the case of the Transforming Growth Factor-beta
isoforms, which play critical roles in growth regulation and development), and the organism
species the growth factor comes from.
Cell characterization Phenotypic/genotypic characterization of cells before their seeding onto biomaterials: evaluation
of the expression of cell surface markers through flow cytometry analysis. [optional]
In vivo experiment Host features Species of the host, age [optional], gender, weight and health status of the host.
Implant features Orthotopic (implant placed in the original, correct site) or ectopic (implant inserted under skin);
time the biomaterial remains within the animal model; dimension of the implanted samples
[optional]; surgical procedure for the implant.
Results In vitro matrix deposition Evaluation and report of the matrix deposition in in vitro experiments, through morphology,
mechanical, biomolecular and biochemical tests (see tests listed below), to obtain a qualitative
and quantitative evaluation of scaffold performances. All the results have to be reported
specifying the technique used, the applied protocol, the value and measurement unit of the
result (in case of quantitative analysis) or the discussion of the result (in case of qualitative
analysis).
In vivo tissue generation Evaluation and report of the growth of tissue in in vivo experiments, through morphology,
mechanical, biomolecular and biochemical tests (see tests listed below), to obtain a qualitative
and quantitative evaluation of scaffold performances. All the results have to be reported
specifying the technique used, the applied protocol, the value and measurement unit of the




Kinetics, amount or percentage of biomaterial degradation/resorption over time, either in vitro or
in vivo [optional].
Adverse effects Eventual biomaterial toxicity, evaluated either in vitro (reporting cytotoxicity tests) or in vivo (such
as inflammatory response, foreign body reaction, release of degradation by-products)
Tissue/matrix
characterization
Morphology tests Results of histological and microscopy tests (i.e. SEM, TEM) used to study structures of the
generated tissue/matrix (at level of tissue and cell).
Mechanical tests Values of main indexes (such as Young module) to define mechanical goodness of the generated
tissue/matrix.
Biomolecular tests Genes and proteins level within tissue/matrix cells. Used technique (typically real time RT-PCR or
immunohistochemistry; recently high-throughput technologies such as gene expression
microarray were introduced). Examples of bone and cartilage markers are type I collagen, RUNX2
protein, osteonectin, osteopontin, osteocalcin, SOX9.
Biochemical tests Amount of calcium and mineralization (for bone), amount of aggrecan and glycosaminoglycan
(for cartilage); the exploited technique.
Features are grouped by ‘concepts’, and detailed listing mandatory and non-compulsory (flagged as [optional]) aspects to be reported for describing a bone/
cartilage experiment.
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relation represents the link between a term that plays a role
in a process and the term that describes the process. In RO
relations exist that could define similar concepts (for exam-
ple participates_in), but they are oriented exclusively to
model the biological context. ‘intervenes_in’ is intended to
be general purpose, and its formal definition is: given a
process P that brings from state S1 (at time t1) to state S2
(at time t2>t1), R intervenes in P if R is a requirement of
P; in other words, an instance p of P can exist if and only
if an instance r of R exists in the interval (t1, t2). An exam-
ple of its usage in BCTEO is: Growth environment inter-
venes_in Cell expansion. Moreover, in OBO format
ontology terms have optional fields such as definition,
synonyms, comments, or cross-references that can provide
additional information to the term name and its relation
with parents and children. A partial overview of the
BCTEO is shown in Figure 2.
To avoid the ex-novo development of concepts pre-
viously described in other ontologies, terms already
defined are here reported, together with the citation of the
related cross-reference. While for the concerns of biologi-
cal concepts like tissues, cells, cell features, cell types etc.
many already defined terms were available in CL, BTO,
NCBITaxon and other biology oriented ontologies (for
example, ‘Real time polymerase chain reaction’ is defined
in OBI, presenting 0000893 identifier; ‘Chondrocyte’
belongs to BTO with 0000249 identifier), little contribu-
tions were provided by existing structured vocabularies to
describe and define investigations on the in vitro and in
vivo outcomes. As emerges from Figure 3, where BCTEO
relations with external vocabularies and ontologies are
pointed out, almost nothing was found in available ontolo-
gies concerning biomaterials. This is consistent with the
necessity for a concept organization in tissue engineering
domain: actually the aim of BCTEO is filling the gap
between the biological field, that is a well defined domain,
and the material science aspect, that is poor of semantic
instruments.
Biomaterials have been classified on the basis of their
chemical composition into ‘ceramics’, ‘polymers’, ‘metals’,
‘gels’ and ‘composites’. Materials are even characterized
by specific features, which define their behaviour consid-
ering two perspectives: (1) the intrinsic properties
describe chemical and physical aspects and can be asso-
ciated directly to each material; (2) the scaffold-related
properties depend on the size, the shape and the surface
of the graft and are clustered into mechanical and mor-
phological aspects.
Tools validation
BCTEO and the proposed guidelines have been validated
through the consensus of experts. A survey has been
designed and distributed to 12 skilled tissue engineers
from all over the world (see Table 4 for major details
about panel composition). A questionnaire has been orga-
nized in four sections, showing the main concepts of
BCTEO and guidelines: biomaterial, in-vitro analysis,
in-vivo analysis, and cellular response. For each area of
interest a set of crucial aspects has been identified and
proposed to the experts, asking them to provide a score of
relevance (1=’absolutely not necessary’, 2=’not necessary’,
3=’optional’, 4=’necessary’, 5= ‘absolutely necessary’).
For each concept, the mean score obtained from all
the contacted scientists has been calculated, enabling a
relevance comparison (Figure 4). 80% of the concepts
obtained a score between 5.0 (maximum mean score)
and 4.0 (solid vertical line in Figure 4), confirming that
the experts consider as widely necessary those aspects,
in order to thoroughly describe a tissue engineering
experiment. Other features (20% of the total number of
proposed concepts) obtained a partial consensus among
the experts (showing a mean score between 3.9 and 3.0
(the minimum value that defines a positive relevance of
the concept), thus asserting the interest for these con-
cepts, but not their absolute relevance. These features
have been included in BTCEO, and flagged as recom-
mended but not compulsory in the guidelines. No fea-
tures obtained a score lower than 3.0 (the minimum
mean score obtained was 3.8), thus meaning that all the
proposed concepts have been considered useful for
clearly describing a tissue engineering experiment. An
interesting feedback of the survey is represented by the
additional suggestions provided by the experts: proposed
extra-features (such as the biomaterial cytotoxicity, the
surgical technique used for the implant or the cell seed-
ing efficiency) have been added in BTCEO and in the
guidelines, thus enriching the provided tools with the
community contribution.
Discussion
Several researches are targeted to the design and realiza-
tion of biomaterial scaffolds guiding cells to tissue
growth. Sharing and collecting experimental data about
different biomaterials and diverse experimental condi-
tions could enable data correlation and comparisons,
finally supporting the formulation of new hypotheses
about the existing materials or the generation of novel
intelligent engineered scaffolds. Nevertheless, computa-
tional technologies that catalyse discovery by integrating
tissue engineering knowledge are few and far from being
widely exploited. In this perspective, authors developed
two resources helping data sharing and reuse.
Theoretical guidelines have been defined to support
information and data structuring in tissue engineering.
Reporting data by maintaining adherence to the pro-
posed guidelines will result in clearer scientific publica-
tions, and will promote the results’ interpretability and
comprehension. Currently, the experimental outcome is
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often presented in qualitative terms. For this reason, a
whole section of the guidelines has been dedicated to
results description. In fact, numerical quantification is a
crucial aspect in all scientific fields, since the improvement
of clearness in data exposition (by providing numerical
results) would enable their better interpretation, automatic
collection and aggregated analysis, thus easily achieving the
inference of scaffolds’ performance and their comparison.
Figure 2 Partial hierarchical overview of BCTEO ontology. It was created with OBO-Edit software. A relation, represented as an arrow, links
each term to its parent. Exploited relations are: is_a (I), characterizes, intervenes_in, part_of (P), derives_from.
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Unfortunately, few analysis techniques report results quan-
tification on numerical basis, while a widely exploited
approach for results presentation consists in showing fig-
ures reporting images (i.e. for what concerns histology
data) or diagrams (such as histograms showing genes or
proteins expression under different conditions). Therefore,
results evaluation and comparison are often performed
visually, obtaining not quantifiable data. For example, his-
tological data showing the potential of scaffolds to support
newly formed tissue formation is always reported as a
stained image, although it should be shown as a numerical
value, besides the histological section. To this aim, in the
last years image processing approaches have been pub-
lished, addressed to quantify the newly formed tissue and/
or the matrix deposited within the implant, through seg-
mentation algorithms for either histological [17-19] or
x-ray [20] images. Other than helping to move towards
more reliable comparative analysis, the effort to provide
structured information could support the rapid, systematic
capture of bone/cartilage regenerative data and their
Figure 3 Relation between BCTEO and other biomedical ontologies. Domain main concepts (Biomaterial, Experiment, Organism, Tissue,
Cellular Response) are shown associated to the external ontologies through the evidenced relations.






United States 2 0
Total no of experts 8 4
Gender and provenance characterization of the panel of tissue engineers
chosen to comment and validate the developed tools.
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maintenance in databases, thereby improving access to
valuable information.
In addition to the guidelines an ontology has been
proposed, whose terms mainly map on information and
concepts suggested in the roadmap sections. BCTEO
represents the first instrument for semantic approach in
tissue engineering field: among other major applications,
this ontology can be used as the standardized semantic
layer when developing structured collection of data in
this domain. Relying on ontologies, database technolo-
gies can, for example, promote data comparison and
enable faster and more effective queries: characterized
by a hierarchical structure, a query on the term ‘metal’
will retrieve even children terms such as ‘stainless steel’
and ‘titanium’, that would be excluded from the results
not considering the semantic approach. Another inter-
esting aspect of BCTEO concerns its devotion to a
multidisciplinary scientific field that results in the inte-
gration of the biological perspective (for what concerns
the experimental steps), with the materials science
details (for describing the chemical/physical features of
the developed scaffolds) and the measurement methods
(regarding different techniques to test the neo-formed
tissue): this generates a wide presence of cross-references
among BCTEO terms and definitions from external
ontologies.
Both the developed tools have been validated through a
survey proposed to a panel of expert tissue engineers.
Some consideration emerges from resulting data. Interest-
ingly, all experts involved in the validation assigned the
highest scores to concepts belonging to the “cellular
response” section, thus highlighting the importance the
scientific community feels about reporting complete
details concerning this experimental aspect. Surprisingly,
in fact details about molecular, biochemical, mechanical
analysis after cell-biomaterial interaction are often missing
or incomplete; moreover, only in few cases results are
shown as numerical values in scientific papers.
Another interesting observation related to the end-
users validation was the disagreement about the features
that describe the “cell” section: although experts claim to
appreciate a wide number of details about cell source and
expansion/culture protocols, they often disagree on the
type of required information. This outcome reflects the
scientific literature scenario, where experimental data are
typically reported in heterogeneous, not standardized
mode. In the here presented tools a wide number of fea-
tures have been considered, in order to integrate different
Figure 4 Distribution of the mean scores obtained by survey’s questions. The whole set of questions obtained a mean score widely upper
than the sufficiency (represented by score 3.0). On the basis of the mean score different guidelines’ aspects are flagged as optional (to distinguish
to the other, that are mandatory by default). None of the proposed aspects has been recognized as useless.
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needs and finally obtain a complete set of mandatory
features.
Conclusions
Regulation of bone and cartilage tissue formation and
remodelling is one of the main targets of tissue engineer-
ing research field. Lots of experiments have been per-
formed in this context, testing the effectiveness of novel
substitute materials that promote tissue regeneration.
Although widely investigated, it remains a not completely
elucidated research field, due to its multidisciplinarity
and the complexity of the factors intervening in the
experiments. To help scientists in highlighting advan-
tages and disadvantages of biomaterials a theoretical
roadmap for experiments description and an ontology for
semantic approaches have been designed. Both act in the
perspective of information standardization and data shar-
ing, aiming to facilitate data comprehension, helping
information classification, recognition and annotation,
promoting comparison between works to better evaluate
materials response, and hypothesising novel graft features
and compositions. The overall platform has been vali-
dated by means of the end-user perspective.
Considering that tissue engineering is a discipline that
concerns many scientific aspects, traverses many scales
(micro-macro levels), and employs many data types,
BCTEO represents a first attempt to standardize this var-
iegated domain knowledge, and can provide a suitable
mean to integrate data across the field. In particular, data-
base technology can be usefully integrated with an ontol-
ogy layer, thus improving data integration and simplifying
information searching.
Finally, the framework described in this paper has been
applied in the context of bone and cartilage tissue engi-
neering: it represents one of the most widely investigated
fields of regenerative medicine, due to the constant
increasing of articular-skeletal diseases/trauma, mostly in
young and sportive people. However, tissue engineering
is not restricted to bone and cartilage aspects, and they
just represent a starting point to develop informatics
tools for regenerative medicine. Therefore, it is worth
noting that the here presented tools (guidelines and
ontology) can be generalized, thus becoming a useful
instrument for semantic approach in the entire tissue
engineering field.
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